45 results
8-K
2ee66ye4
13 Oct 21
BeiGene Announces First Regulatory Approval in Australia for BRUKINSA® (Zanubrutinib) for Treatment of Patients with Waldenström’s Macroglobulinemia
5:27pm
8-K
EX-99.1
3vuyjp 6p0ohf
6 May 21
BeiGene Reports First Quarter 2021 Financial Results
4:26pm
8-K
EX-99.1
miovx4l3ih5qv06hrrxe
5 Nov 20
BeiGene Reports Third Quarter 2020 Financial Results
4:58pm
8-K
EX-99.1
c7todbk9s6913zq66
6 Aug 20
BeiGene Reports Second Quarter 2020 Financial Results
4:13pm
8-K
EX-99.1
54gtx1h3jiw
11 May 20
BeiGene Reports First Quarter 2020 Financial Results
4:20pm